Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    19596163 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease
Condition: Proteinuric Renal Disease
Intervention: Drug: paricalcitol (initial dose 1 mcg orally per day)

Study has passed its completion date and status has not been verified in more than two years.